GGrantIndex
← Leaderboards

Asha Bhaskaran Pillai

Stanford University

$2,775,962
Attributed
$2,775,962
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $445.6K · FY200821
$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$2,775,962 · 3

By mechanism

R01$1,677,342 · 1
K08$652,995 · 1
R56$445,625 · 1

Top collaborators

No co-investigators on record.

Most similar at Stanford University

Same institution · by research overlap

Others in their field

Top investigators on “Non-Malignant

Research focus

Non-MalignantOryctolagus CuniculusMouse ModelMaintenanceInterleukin-4In VivoGenerationsEngraftmentLaboratoriesHistocompatibilityCytokineInsightAntithymoglobulinIn VitroBeta ThalassemiaAllogeneic Bone Marrow TransplantationAllogenicBone Marrow TransplantationImmuneImmune ResponseHematological DiseaseCellsConditioningPlay

Grant awards (13)

NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES$441,168
R01 · FY2021 · HL · contact PI
NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES$441,168
R01 · FY2020 · HL · contact PI
NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES$383,750
R01 · FY2019 · HL · contact PI
NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES$27,506
R01 · FY2019 · HL · contact PI
NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES$383,750
R01 · FY2018 · HL · contact PI
NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES$359,056
R56 · FY2015 · HL · contact PI
NOVEL INNATE MECHANISMS OF IMMUNE TOLERANCE INDUCTION IN ALLOGENEIC HCT FOR HEMOGLOBINOPATHIES$86,569
R56 · FY2015 · HL · contact PI
REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIAS$130,599
K08 · FY2012 · HL · contact PI
REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIAS$130,599
K08 · FY2011 · HL · contact PI
REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIAS$130,599
K08 · FY2010 · HL · contact PI
REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIAS$88,395
K08 · FY2009 · HL · contact PI
REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIAS$42,204
K08 · FY2009 · HL · contact PI
REGULATORY T CELLS, MIXED CHIMERISM: A NOVEL TRANSPLANT STRATEGY FOR THALASSEMIAS$130,599
K08 · FY2008 · HL · contact PI